Friday 6 November 2026
Export GEVO’s income statement to Excel — free account
Gevo, Inc.
GEVO Basic Materials Specialty Chemicals
Gevo, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $160.6 million, up 849.3% from fiscal 2024.
- Revenue
- +7.11%
- EPS
- −7,600.0%
- Free cash flow
- −167.5%
- Total debt
- +20.0%
Quarter to June 2026, against a year earlier
1.39
0.17
+13.93%
Follow GEVO
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (56.98%) | (7.37%) | (7.08%) | (9.27%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
4 | 6 | 5 | 4 | |
| (35.69%) | (5.08%) | (5.19%) | (7.00%) | ||
ROIC |
(29.79%) | (0.58%) | (2.42%) | (4.69%) | |
Return on Tangible Assets |
(70.48%) | (7.56%) | (8.09%) | (11.05%) | |
Average Days of Receivables |
24.61 | 20.37 | 19.08 | 23.37 | |
Free Cash Flow per Share |
(0.24) | (0.18) | (0.19) | (0.37) | |
Free Cash Flow |
(56.65) | (43.65) | (43.51) | (85.73) | |
Capital Expenditures |
(40.40) | (33.15) | (30.11) | (33.53) | |
| Other line items | |||||
Cash ROIC |
(11.35%) | (6.29%) | (5.87%) | (12.16%) | |
Accounts Receivable Turnover |
15.44 | 16.24 | 29.72 | 26.42 | |
Accounts Payable Turnover |
2.28 | 3.12 | 2.91 | 2.44 | |
Inventory Turnover |
4.83 | 4.44 | 7.23 | 5.85 | |
Average Days of Payables |
139.31 | 111.05 | 156.33 | 180.04 | |
Days of Inventory on Hand |
80.54 | 92.42 | 81.68 | 98.50 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
8.88% | 8.42% | 10.09% | 10.02% | |
Selling, General and Administrative Expense of Revenue |
32.92% | 32.30% | 31.88% | 36.36% | |
Share Based Compensation of Revenue |
5.48% | 5.40% | 5.73% | 7.24% | |
Interest Coverage |
(8.81) | (0.26) | (1.15) | (2.70) | |
Operating CF/Net income |
0.08 | 0.31 | 0.40 | 1.16 | |
Depreciation/Fixed assets |
0.13 | 0.09 | 0.08 | 0.08 | |
Capex/Depreciation |
(1.34) | (1.08) | (1.03) | (1.21) | |
Revenue per Share |
0.75 | 0.74 | 0.69 | 0.52 | |
Operating CF per Share |
(0.07) | (0.04) | (0.06) | (0.22) | |
Capex per Share |
(0.17) | (0.14) | (0.13) | (0.14) | |
Capex to Sales |
0.23 | 0.19 | 0.19 | 0.28 |
Columns are period end dates